4Piche ME,Despres JP,Pascot A,et al.Predictors of the development of impaired fasting glucose versus impaired glucose tolerance are partly different in men:a 6-year follow-up study[J].Diabetologia,2004,47:590.
9Pan XR,Li GW,Hu YH,et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997,20:537-544.
10Tominaga M. Epidemiology on impaired glucose tolerance. Nippon Rinsho, 1996,54:2643-2648.
2Rocco MV, Frankenfield DL, Hopson SD, et al. Relationship between clinical performance measures and outcomes anaong patients receiving long - term hemodialysis. Ann Intern Med, 2006,145(7) :512 - 519.
3中华医学会糖尿病学分会.中国糖尿病防治指南.北京:北京医科大学出版社,2005.1-54.
4Narita T, Hosoba M, Kakei M, et al. Increased urinary excretions of immunoglobuling, eeruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care,2006,29(1) : 142 - 144.
5Watanabe S,Okura T,Kurata M,et al. Valsartan reduces serum cystatin C and therenal vascular resistance in patients with essential hypertension. Clin Exp Hypertens, 2006,28 (10) : 451 - 461.
6Kobayashi K, Tada K, I tabe H, et al. Distinguished effects of antiphospholipid antibodies and anti - oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus, 2007 . 16 (11) : 929 - 938.
7Fujita H, Koshimura J, Sato T, et al. Effects of long - term pravastatin treatment on serum and urinary raonocyte chemcat- tractant protein- 1 levels and renal function in type 2 diabetic patients with normoalbuminuria. Ren Fail, 2007,29 (7) : 791 - 796.
8Fujita H, Koshimura J, Sato T, et al. Effects of long - term pravastatin treatment on serum and urinary monocyte chemoat- tractant protein- 1 levels and renal function in type 2 diabetic patients with normoalbuminuria. Ren Fail, 2007,29(7) : 791 - 796.
9陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2006.1033-1034.
10Mackinnon B,Shakerdi L,Deighan CJ,et al. Urinary transferrin, high molecular weight proteinuria and the progression of renal disease. Clin Nephrol, 2003,59 (4) : 252 - 258.
